{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:25:09Z","timestamp":1793316309074,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["P1BSP3_200054"],"award-info":[{"award-number":["P1BSP3_200054"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030_1449493"],"award-info":[{"award-number":["320030_1449493"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030_170249"],"award-info":[{"award-number":["320030_170249"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PZ00P3_167952"],"award-info":[{"award-number":["PZ00P3_167952"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Psychedelics have emerged as promising candidate treatments for various psychiatric conditions, and given their clinical potential, there is a need to identify biomarkers that underlie their effects. Here, we investigate the neural mechanisms of lysergic acid diethylamide (LSD) using regression dynamic causal modelling (rDCM), a novel technique that assesses whole-brain effective connectivity (EC) during resting-state functional magnetic resonance imaging (fMRI). We modelled data from two randomised, placebo-controlled, double-blind, cross-over trials, in which 45 participants were administered 100\u2009\u03bcg LSD and placebo in two resting-state fMRI sessions. We compared EC against whole-brain functional connectivity (FC) using classical statistics and machine learning methods. Multivariate analyses of EC parameters revealed predominantly stronger interregional connectivity and reduced self-inhibition under LSD compared to placebo, with the notable exception of weakened interregional connectivity and increased self-inhibition in occipital brain regions as well as subcortical regions. Together, these findings suggests that LSD perturbs the Excitation\/Inhibition balance of the brain. Notably, whole-brain EC did not only provide additional mechanistic insight into the effects of LSD on the Excitation\/Inhibition balance of the brain, but EC also correlated with global subjective effects of LSD and discriminated experimental conditions in a machine learning-based analysis with high accuracy (91.11%), highlighting the potential of using whole-brain EC to decode or predict subjective effects of LSD in the future.<\/jats:p>","DOI":"10.1038\/s41386-023-01574-8","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T13:04:40Z","timestamp":1682427880000},"page":"1175-1183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity"],"prefix":"10.1038","volume":"48","author":[{"given":"Peter","family":"Bedford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1772-9239","authenticated-orcid":false,"given":"Daniel J.","family":"Hauke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9210-2562","authenticated-orcid":false,"given":"Monika","family":"Nagy-Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3143-1519","authenticated-orcid":false,"given":"Friederike","family":"Holze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5954-4446","authenticated-orcid":false,"given":"Patrick","family":"Vizeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-9659","authenticated-orcid":false,"given":"Matthias E.","family":"Liechti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5792-3987","authenticated-orcid":false,"given":"Stefan","family":"Borgwardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea O.","family":"Diaconescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"1574_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.12.040","volume":"142","author":"JJ Rucker","year":"2018","unstructured":"Rucker JJ, Iliff J, Nutt DJ. Psychiatry & the psychedelic drugs. past, present & future. Neuropharmacology. 2018;142:200\u201318.","journal-title":"Neuropharmacology"},{"key":"1574_CR2","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1177\/0269881112439253","volume":"26","author":"TS Krebs","year":"2012","unstructured":"Krebs TS, Johansen P-\u00d8. Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials. J Psychopharmacol. 2012;26:994\u20131002.","journal-title":"J Psychopharmacol"},{"key":"1574_CR3","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","volume":"79","author":"MP Bogenschutz","year":"2022","unstructured":"Bogenschutz MP, et al. Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2022;79:953\u201362.","journal-title":"JAMA Psychiatry"},{"key":"1574_CR4","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","volume":"387","author":"GM Goodwin","year":"2022","unstructured":"Goodwin GM, et al. Single-dose psilocybin for a treatment-resistant episode of major depression. N Engl J Med. 2022;387:1637\u201348.","journal-title":"N Engl J Med"},{"key":"1574_CR5","first-page":"215","volume":"95","author":"F Holze","year":"2022","unstructured":"Holze F, Gasser P, M\u00fcller F, Dolder PC, Liechti ME. Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness a randomized, double-blind, placebo-controlled Phase II study. Biol Psychiatry. 2022;95:215\u201323.","journal-title":"Biol Psychiatry."},{"key":"1574_CR6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths RR, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol. 2016;30:1181\u201397.","journal-title":"J Psychopharmacol"},{"key":"1574_CR7","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross S, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol. 2016;30:1165\u201380.","journal-title":"J Psychopharmacol"},{"key":"1574_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0269881114555249","volume":"29","author":"P Gasser","year":"2015","unstructured":"Gasser P, Kirchner K, Passie T. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects. J Psychopharmacol. 2015;29:57\u201368.","journal-title":"J Psychopharmacol"},{"key":"1574_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/jamapsychiatry.2020.2171","volume":"78","author":"D Nutt","year":"2021","unstructured":"Nutt D, Carhart-Harris R. The current status of psychedelics in psychiatry. JAMA Psychiatry. 2021;78:121\u20132.","journal-title":"JAMA Psychiatry"},{"key":"1574_CR10","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cub.2016.02.010","volume":"26","author":"E Tagliazucchi","year":"2016","unstructured":"Tagliazucchi E, et al. Increased global functional connectivity correlates with LSD-induced ego dissolution. Curr Biol. 2016;26:1043\u201350.","journal-title":"Curr Biol"},{"key":"1574_CR11","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1002\/hbm.23224","volume":"37","author":"L Roseman","year":"2016","unstructured":"Roseman L, et al. LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion. Hum Brain Mapp. 2016;37:3031\u201340.","journal-title":"Hum Brain Mapp"},{"key":"1574_CR12","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.euroneuro.2016.03.018","volume":"26","author":"M Kaelen","year":"2016","unstructured":"Kaelen M, et al. LSD modulates music-induced imagery via changes in parahippocampal connectivity. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol. 2016;26:1099\u2013109.","journal-title":"Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol"},{"key":"1574_CR13","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1073\/pnas.1518377113","volume":"113","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL, et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci USA. 2016;113:4853\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1574_CR14","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/acps.12818","volume":"136","author":"F M\u00fcller","year":"2017","unstructured":"M\u00fcller F, et al. Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations. Acta Psychiatr Scand. 2017;136:648\u201357.","journal-title":"Acta Psychiatr Scand"},{"key":"1574_CR15","doi-asserted-by":"crossref","unstructured":"Preller K. et al. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor. eLife. 2018;7:e35082.","DOI":"10.7554\/eLife.35082"},{"key":"1574_CR16","doi-asserted-by":"crossref","unstructured":"Barnett L., Muthukumaraswamy S. D., Carhart-Harris R. L. & Seth A. K. Decreased directed functional connectivity in the psychedelic state. NeuroImage. 2020;209.","DOI":"10.1016\/j.neuroimage.2019.116462"},{"key":"1574_CR17","first-page":"461","volume":"5","author":"AK Bershad","year":"2020","unstructured":"Bershad AK, et al. Preliminary report on the effects of a low dose of LSD on resting-state amygdala functional connectivity. Cognitive Neurosci Neuroimaging. 2020;5:461\u20137.","journal-title":"Cognitive Neurosci Neuroimaging"},{"key":"1574_CR18","first-page":"17653","volume":"227","author":"AI Luppi","year":"2018","unstructured":"Luppi A. I. et al. LSD alters dynamic integration and segregation in the human brain. NeuroImage. 2021;227:17653.","journal-title":"NeuroImage"},{"key":"1574_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neuropharm.2017.10.039","volume":"142","author":"C Timmermann","year":"2018","unstructured":"Timmermann C, et al. LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm. Neuropharmacology. 2018;142:251\u201362.","journal-title":"Neuropharmacology"},{"key":"1574_CR20","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1073\/pnas.1815129116","volume":"116","author":"K Preller","year":"2019","unstructured":"Preller K, et al. Effective connectivity changes in LSD-induced altered states of consciousness in humans. Proc Natl Acad Sci USA. 2019;116:2743\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1574_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cercor\/1.1.1","volume":"1","author":"DJ Felleman","year":"1991","unstructured":"Felleman DJ, Van Essen DC. Distributed hierarchical processing in the primate cerebral cortex. Cerebral Cortex. 1991;1:1\u201347.","journal-title":"Cerebral Cortex"},{"key":"1574_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/cercor\/bhs270","volume":"24","author":"NT Markov","year":"2014","unstructured":"Markov NT, et al. A weighted and directed interareal connectivity matrix for macaque cerebral cortex. Cerebral Cortex. 2014;24:17\u201336.","journal-title":"Cerebral Cortex"},{"key":"1574_CR23","doi-asserted-by":"crossref","unstructured":"Friston K. Functional and effective connectivity in neuroimaging: a synthesis. Hum Brain Mapp. 1994;2:56\u201378.","DOI":"10.1002\/hbm.460020107"},{"key":"1574_CR24","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.neuroimage.2017.02.090","volume":"155","author":"S Fr\u00e4ssle","year":"2017","unstructured":"Fr\u00e4ssle S, et al. Regression DCM for fMRI. NeuroImage. 2017;155:406\u201321.","journal-title":"NeuroImage"},{"key":"1574_CR25","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S1053-8119(03)00202-7","volume":"19","author":"KJ Friston","year":"2003","unstructured":"Friston KJ, Harrison L, Penny W. Dynamic causal modelling. NeuroImage. 2003;19:1273\u2013302.","journal-title":"NeuroImage"},{"key":"1574_CR26","doi-asserted-by":"crossref","unstructured":"Fr\u00e4ssle S. et al. A generative model of whole-brain effective connectivity. NeuroImage. 2018;179:505\u201329.","DOI":"10.1016\/j.neuroimage.2018.05.058"},{"key":"1574_CR27","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1002\/hbm.25357","volume":"42","author":"S Fr\u00e4ssle","year":"2021","unstructured":"Fr\u00e4ssle S, et al. Regression dynamic causal modeling for resting-state fMRI. Human Brain Mapping. 2021;42:2159\u201380.","journal-title":"Human Brain Mapping"},{"key":"1574_CR28","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1038\/npp.2016.82","volume":"41","author":"PC Dolder","year":"2016","unstructured":"Dolder PC, Schmid Y, M\u00fcller F, Borgwardt S, Liechti ME. LSD acutely impairs fear recognition and enhances emotional empathy and sociality. Neuropsychopharmacology. 2016;41:2638\u201346.","journal-title":"Neuropsychopharmacology."},{"key":"1574_CR29","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.nicl.2018.03.005","volume":"18","author":"F M\u00fcller","year":"2018","unstructured":"M\u00fcller F, Dolder PC, Schmidt A, Liechti ME, Borgwardt S. Altered network hub connectivity after acute LSD administration. NeuroImage Clinical. 2018;18:694\u2013701.","journal-title":"NeuroImage Clinical"},{"key":"1574_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41386-019-0569-3","volume":"45","author":"F Holze","year":"2020","unstructured":"Holze F, et al. Distinct acute effects of LSD, MDMA and D-amphetamine in healthy subjects. Neuropsychopharmacology. 2020;45:462\u201371.","journal-title":"Neuropsychopharmacology"},{"key":"1574_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1055\/s-2007-979351","volume":"31","author":"A Dittrich","year":"1998","unstructured":"Dittrich A. The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry. 1998;31:80\u20134.","journal-title":"Pharmacopsychiatry."},{"key":"1574_CR32","doi-asserted-by":"publisher","first-page":"e12412","DOI":"10.1371\/journal.pone.0012412","volume":"5","author":"E Studerus","year":"2010","unstructured":"Studerus E, Gamma A, Vollenweider FX. Psychometric evaluation of the altered states of consciousness rating scale (OAV). PloS One. 2010;5:e12412.","journal-title":"PloS One."},{"key":"1574_CR33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc, Ser B (Method). 1995;57:289\u2013300.","journal-title":"J R Stat Soc, Ser B (Method)"},{"key":"1574_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.neuroimage.2010.07.034","volume":"56","author":"A Krishnan","year":"2011","unstructured":"Krishnan A, Williams LJ, McIntosh AR, Abdi H. Partial Least Squares (PLS) methods for neuroimaging: a tutorial and review. NeuroImage. 2011;56:455\u201375.","journal-title":"NeuroImage."},{"key":"1574_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45:5\u201332.","journal-title":"Mach Learn"},{"key":"1574_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0361-9230(01)00646-3","volume":"56","author":"FX Vollenweider","year":"2001","unstructured":"Vollenweider FX, Geyer MA. A systems model of altered consciousness: integrating natural and drug-induced psychoses. Brain Research Bulletin. 2001;56:495\u2013507.","journal-title":"Brain Research Bulletin"},{"key":"1574_CR37","doi-asserted-by":"crossref","unstructured":"Carhart-Harris R. L. et al. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Hum Neurosci. 2014;8.","DOI":"10.3389\/fnhum.2014.00020"},{"key":"1574_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neuropharm.2018.03.010","volume":"142","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris RL. The entropic brain-revisited. Neuropharmacology. 2018;142:167\u201378.","journal-title":"Neuropharmacology"},{"key":"1574_CR39","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1124\/pr.118.017160","volume":"71","author":"RL Carhart-Harris","year":"2019","unstructured":"Carhart-Harris RL, Friston KJ. Rebus and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacol Rev. 2019;71:316\u201344.","journal-title":"Pharmacol Rev"},{"key":"1574_CR40","doi-asserted-by":"crossref","unstructured":"Girn M. et al. Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex. NeuroImage. 2022;256:119220.","DOI":"10.1016\/j.neuroimage.2022.119220"},{"key":"1574_CR41","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE. Psychedelics. Pharmacol Rev. 2016;68:264\u2013355.","journal-title":"Pharmacol Rev"},{"key":"1574_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0006-8993(99)01224-X","volume":"825","author":"GK Aghajanian","year":"1999","unstructured":"Aghajanian GK, Marek GJ. Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res. 1999;825:161\u201371.","journal-title":"Brain Res"},{"key":"1574_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuroimage.2017.07.020","volume":"159","author":"CR Lewis","year":"2017","unstructured":"Lewis CR, et al. Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow. NeuroImage. 2017;159:70\u20138.","journal-title":"NeuroImage"},{"key":"1574_CR44","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","volume":"45","author":"N Mason","year":"2020","unstructured":"Mason N, et al. Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin. Neuropsychopharmacology. 2020;45:2003\u201311.","journal-title":"Neuropsychopharmacology"},{"key":"1574_CR45","first-page":"120","volume":"37","author":"V Beliveau","year":"2017","unstructured":"Beliveau V, et al. A high-resolution in vivo atlas of the human brain\u2019s serotonin system. J Neurosci. 2017;37:120\u20138.","journal-title":"J Neurosci"},{"key":"1574_CR46","doi-asserted-by":"publisher","first-page":"8846","DOI":"10.1523\/JNEUROSCI.20-23-08846.2000","volume":"20","author":"JL Scruggs","year":"2000","unstructured":"Scruggs JL, Patel S, Bubser M, Deutch AY. DOI-induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons. J Neurosci. 2000;20:8846\u201352.","journal-title":"J Neurosci."},{"key":"1574_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0304-3940(03)00547-0","volume":"346","author":"JL Scruggs","year":"2003","unstructured":"Scruggs JL, Schmidt D, Deutch AY. The hallucinogen 1-[2, 5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats. Neurosci Lett. 2003;346:137\u201340.","journal-title":"Neurosci Lett."},{"key":"1574_CR48","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/brain\/awt257","volume":"136","author":"R Jardri","year":"2013","unstructured":"Jardri R, Deneve S. Circular inferences in schizophrenia. Brain. 2013;136:3227\u201341.","journal-title":"Brain"},{"key":"1574_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms14218","volume":"8","author":"R Jardri","year":"2017","unstructured":"Jardri R, Duverne S, Litvinova AS, Den\u00e8ve S. Experimental evidence for circular inference in schizophrenia. Nat Commun. 2017;8:1\u201313.","journal-title":"Nat Commun"},{"key":"1574_CR50","doi-asserted-by":"crossref","unstructured":"Leptourgos P., Bouttier V., Den\u00e8ve S. & Jardri R. From hallucinations to synaesthesia: a circular inference account of unimodal and multimodal erroneous percepts in clinical and drug-induced psychosis. Neurosci Biobehav Rev. 2022;104593.","DOI":"10.1016\/j.neubiorev.2022.104593"},{"key":"1574_CR51","doi-asserted-by":"publisher","first-page":"104689","DOI":"10.1016\/j.neubiorev.2022.104689","volume":"138","author":"DE-W McCulloch","year":"2022","unstructured":"McCulloch DE-W, et al. Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses. Neurosci Biobehav Rev. 2022;138:104689.","journal-title":"Neurosci Biobehav Rev"},{"key":"1574_CR52","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","volume":"78","author":"Y Schmid","year":"2015","unstructured":"Schmid Y, et al. Acute effects of lysergic acid diethylamide in healthy subjects. Biol Psychiatry. 2015;78:544\u201353.","journal-title":"Biol Psychiatry"},{"key":"1574_CR53","doi-asserted-by":"publisher","first-page":"e22265","DOI":"10.1002\/jcla.22265","volume":"32","author":"PC Dolder","year":"2018","unstructured":"Dolder PC, Liechti ME, Rentsch KM. Development and validation of an LC-MS\/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial. J Clin Lab Aanal. 2018;32:e22265.","journal-title":"J Clin Lab Aanal."},{"key":"1574_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneumeth.2016.10.019","volume":"276","author":"L Kasper","year":"2017","unstructured":"Kasper L, et al. The PhysIO toolbox for modeling physiological noise in fMRI data. J Neurosci Methods. 2017;276:56\u201372.","journal-title":"J Neurosci Methods."},{"key":"1574_CR55","doi-asserted-by":"publisher","first-page":"S250\u201363","DOI":"10.1016\/j.neuroimage.2004.05.018","volume":"23","author":"A McIntosh","year":"2004","unstructured":"McIntosh A, Lobaugh N. Partial least squares analysis of neuroimaging data: applications and advances. NeuroImage. 2004;23:S250\u201363.","journal-title":"NeuroImage"},{"key":"1574_CR56","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1093\/cercor\/bhw089","volume":"26","author":"B Mi\u0161i\u0107","year":"2016","unstructured":"Mi\u0161i\u0107 B, et al. Network-level structure-function relationships in human neocortex. Cerebral Cortex. 2016;26:3285\u201396.","journal-title":"Cerebral Cortex"},{"key":"1574_CR57","first-page":"54","volume":"1","author":"B Efron","year":"2018","unstructured":"Efron B. & Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci. 1986;1:54\u201375.","journal-title":"Stat Sci"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01574-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01574-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01574-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T01:23:16Z","timestamp":1729300996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01574-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1574"],"URL":"https:\/\/doi.org\/10.1038\/s41386-023-01574-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.11.01.514687","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"14 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ML is a consultant for Mind Medicine, Inc. The other authors report no financial interests or potential conflicts of interest. Knowhow and data associated with this work and owned by the University Hospital Basel were licensed by Mind Medicine, Inc. Mind Medicine, Inc., had no role in financing, planning, or conducting the present study or the present publication. While Mindmed, Inc., has a collaboration with the University Hospital including a licence for using clinical data exclusively for medication development and regulatory purposes, none of the present data or other fMRI data has been shared with Mindmed, Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}